5 unknown, 1 completed. 2 Not applicable, 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Unknown 1 |
| Phase 2 | 2 | Unknown 2 |
| Phase 3 | 2 | Unknown 2 |
Follow Scotmann Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hypoferritinemia Without Anemia Among Reproductive Age Females Iron III Hydroxide Polymaltose Complex eq. to Elemental Iron, 100 mg, Ferric Carboxymaltose - Hypoferritenemia Without Anemia (HWA), Iron Deficiency Without Anemia) | Not applicable | Completed | Akram Medical Complex | 300 | 2022-10-10 | 2026-07-21 |
| Comparative Pharmacokinetics of Two Different Oral Delivery Systems of Cholecalciferol SunnyD insta ampoule, SunnyD STAT softgel capsule, Placebo SunnyD insta ampoule - Vitamin D Deficiency | Phase 2 | Unknown | Scotmann Pharmaceuticals | 60 | 2022-08-09 | 2022-05-26 |
| Vitamin D, K2 Plus Empagliflozin Combination in Type Two Diabetes Mellitus Oral Hypoglycemic Agents,Oral, Voreta, Voreta plus SunnyD PRO - Diabetes Mellitus | Phase 3 | Unknown | Scotmann Pharmaceuticals | 340 | 2022-08-01 | 2022-06-14 |
| Efficacy and Safety of Apixaban in COVID-19 Coagulopathy Patients With Respiratory Severity Under Critical Care Apixaban, Rivaroxaban - COVID-19 | Phase 2 | Unknown | Scotmann Pharmaceuticals | 40 | 2022-03-01 | 2022-03-10 |
| Vortioxetine as a Novel Anti-depressant With Improvement in Cognitive Abilities Vortioxetine, Venlafaxine - Major Depressive Disorder | Phase 3 | Unknown | Scotmann Pharmaceuticals | 500 | 2022-02-01 | 2021-11-18 |
| Vitamin D and Painful Diabetic Neuropathy Cholecalciferol - Painful Diabetic Neuropathy | Not applicable | Unknown | Baqai Institute of Diabetology and Endocrinology | 216 | 2021-10-29 | 2022-07-21 |
COVID-19 (1) · Depressive Disorder, Major (1) · Diabetes Mellitus (1) · Diabetic Neuropathies (1) · Iron Deficiencies (1) · Vitamin D Deficiency (1)
Cholecalciferol (1) · Control Groups (1) · Rivaroxaban (1) · Venlafaxine Hydrochloride (1) · Vortioxetine (1) · apixaban (1) · ferric carboxymaltose (1)
Pakistan (4)
Abdul Basit, Director (1) · Dr. Abdul Majeed Akhtar, MBBS, PhD (1) · Dr. Rubeena Zakir, MBBS, PhD (1) · Javed Akram, MRCP,FRCP (1) · Muhammad Umar (1) · Muhammad Umar, MBBS,FCPS (1) · Prof. Dr. Muhammad Umar, MBBS (1) · Zaman Shaikh, MRCP,MSc (1)